Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Reata Pharmaceuticals Earnings Preview

Reata Pharmaceuticals (NASDAQ:RETA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Reata Pharmaceuticals will report an earnings per share (EPS) of $-2.15.

Earnings Preview For Atea Pharmaceuticals

Earnings Preview For Atea Pharmaceuticals

Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Atea Pharmaceuticals will report an earnings per share (EPS) of $-0.58.

Krispy Kreme Debuts 'Oh, Honey! Collection' Of Doughnuts

Krispy Kreme Debuts 'Oh, Honey! Collection' Of Doughnuts

Krispy Kreme Inc (NASDAQ: DNUT) is rolling out its latest product line with the limited edition "Oh, Honey! Collection." What Happened: According to the Charlotte, North Carolina-based company, the new collection will consist of three products:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

How Is The Market Feeling About Palo Alto Networks?

Palo Alto Networks's (NASDAQ:PANW) short percent of float has fallen 7.3% since its last report. The company recently reported that it has 7.57 million shares sold short, which is 7.87% of all regular shares that are available for trading.

Why Johnson Outdoors Shares Are Plunging Today

Johnson Outdoors Inc (NASDAQ:JOUT) reported a second-quarter FY22 sales decline of 8% year-on-year to $189.62 million, missing the consensus of $202.32 million. EPS of $0.97 missed the analyst consensus of $1.85. The gross margin contracted 903 basis points Y/Y to 36.2%, primarily due to increased materials and inbound freight costs driven by supply…

Earnings Preview For Quanterix

Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Quanterix will report an earnings per share (EPS) of $-0.61.

Earnings Outlook For UroGen Pharma

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma will report an earnings per share (EPS) of $-1.33.

inkl

Read news from The Economist, FT, and more,
with one subscription

10 Analysts Have This to Say About Texas Roadhouse

10 Analysts Have This to Say About Texas Roadhouse

Analysts have provided the following ratings for Texas Roadhouse (NASDAQ:TXRH) within the last quarter:

CareCloud Beats On Q1 Top and Bottomline; Reiterates FY22 Outlook

CareCloud Beats On Q1 Top and Bottomline; Reiterates FY22 Outlook

CareCloud, Inc (NASDAQ:MTBC) reported first-quarter FY22 revenue growth of 19% year-on-year to $35.3 million beating the consensus of $33.8 million. Adjusted EPS of $0.23 beat the consensus loss of $(0.27). CareCloud held $10.1 million in cash and equivalents and generated $3.1 million in operating cash flow. CareCloud reiterated the FY22 revenue outlook of…

Here's Why ServiceSource Shares Are Soaring Today

Here's Why ServiceSource Shares Are Soaring Today

Concentrix Corporation (NASDAQ:CNXC) agreed to acquire customer journey experience company ServiceSource International, Inc (NASDAQ:SREV) in an all-cash transaction of $1.50 per share. The purchase price represents a 47% premium to ServiceSource's unaffected closing stock price on May 6. Concentrix is a leading provider of customer experience (CX) services and technologies. "We are delighted to join…

27 Recession-Resistant Stocks To Look At Now

27 Recession-Resistant Stocks To Look At Now

When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not exist. On the other hand, recession-resistant companies are what a savvy investor searches for during the absence of a bull market, as we are now.

15 Best Dividend Stocks Across These 3 Key Sectors

15 Best Dividend Stocks Across These 3 Key Sectors

The Fed’s recent interest rate hike of 0.5% is the most significant in over 20 years. Chairman Jerome Powell expects several additional rate hikes through the end of 2022 and into 2023 amid the highest inflation the United States has seen since December 1981.

Short Volatility Alert: Hudson Technologies, Inc.

Short Volatility Alert: Hudson Technologies, Inc.

On Friday, shares of Hudson Technologies, Inc. (NASDAQ: HDSN) saw unusual short activity. After the short activity, the stock price moved up 2.54% to $9.29.

Insurance Stocks Moving In Monday's Intraday Session

Insurance Stocks Moving In Monday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Get all your
news in one place.

100's of premium titles.
One news app.

This Is What Whales Are Betting On Amgen

A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 21 strange trades.

Why Points.com Shares Are Soaring Today

Points.com Inc (NASDAQ:PCOM) (TSX:PTS) entered into an arrangement agreement with Plusgrade Parent L.P. to be acquired for $25 per common share in cash (equivalent to C$32.21). The transaction values Points at ~$385 million on an equity value basis. The consideration represents a 45% premium to Points' closing price on the TSX on May…

Why Hindenburg Research Is Shorting Twitter: 'Musk Holds All The Cards'

Twitter Inc (NYSE: TWTR) shares traded lower by 4% on Monday, well off the $54.20 per-share buyout price Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has agreed to pay to take Twitter private.

Biting Back: Will FAANG Favorites Recapture their Form on Wall Street in Q3 2022?

Despite having an extraordinary track record on Wall Street, 2022 has been a testing year for FAANG stocks. Having taken a battering from tech stock sell-offs in the wake of record-breaking inflation and supply chain issues arising from the Covid-19 pandemic, leading growth stocks have struggled to recapture the form…

Get all your
news in one place.

100's of premium titles.
One news app.

Mid-Day Market Update: Nasdaq Dips 450 Points; Hemisphere Media Group Shares Surge

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping around 450 points on Monday.

Preview: Playtika Holding's Earnings

Playtika Holding (NASDAQ:PLTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Playtika Holding will report an earnings per share (EPS) of $0.22.

Earnings Preview: Gamida Cell

Gamida Cell (NASDAQ:GMDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Gamida Cell will report an earnings per share (EPS) of $-0.34.

A Preview Of Compass Pathways's Earnings

Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Compass Pathways will report an earnings per share (EPS) of $-0.67.

Earnings Outlook For Cerence

Cerence (NASDAQ:CRNC) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cerence will report an earnings per share (EPS) of $0.34.

Earnings Outlook For Immunic

Immunic (NASDAQ:IMUX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Immunic will report an earnings per share (EPS) of $-0.80.

Epizyme Earnings Preview

Epizyme (NASDAQ:EPZM) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Epizyme will report an earnings per share (EPS) of $-0.35.

1 … 557 558 559 560

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Palo Alto Networks

Hindenburg Research

Texas Roadhouse

Compass Pathways

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

376,252 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play